These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 2170290

  • 1. Peptidergic stimulation and inhibition of lacrimal gland adenylate cyclase.
    Cripps MM, Bennett DJ.
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2145-50. PubMed ID: 2170290
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of stimulated lacrimal secretion by [D-Ala2]Met-enkephalinamide.
    Cripps MM, Patchen-Moor K.
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G151-6. PubMed ID: 2546441
    [Abstract] [Full Text] [Related]

  • 3. Gi/Go couple met-enkephalin to inhibition of cholinergic and beta-adrenergic stimulation of lacrimal secretion.
    Meneray MA, Fields TY, Bennett DJ.
    Cornea; 2000 Jan; 19(1):92-8. PubMed ID: 10632016
    [Abstract] [Full Text] [Related]

  • 4. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components.
    Hodges RR, Zoukhri D, Sergheraert C, Zieske JD, Dartt DA.
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):610-9. PubMed ID: 9071214
    [Abstract] [Full Text] [Related]

  • 5. Proenkephalin A derivatives in lacrimal gland: occurrence and regulation of lacrimal function.
    Cripps MM, Bennett DJ.
    Exp Eye Res; 1992 Jun; 54(6):829-34. PubMed ID: 1521577
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW, Tormay A, Podos SM.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
    [Abstract] [Full Text] [Related]

  • 7. Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion.
    Meneray MA, Fields TY, Bennett DJ.
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1261-70. PubMed ID: 9152245
    [Abstract] [Full Text] [Related]

  • 8. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS, Wood CL, Wenger GD, Vassalo LM.
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [Abstract] [Full Text] [Related]

  • 9. Gi2 and Gi3 couple met-enkephalin to inhibition of lacrimal secretion.
    Meneray MA, Fields TY, Bennett DJ.
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1339-45. PubMed ID: 9660481
    [Abstract] [Full Text] [Related]

  • 10. Pertussis-toxin insensitive enkephalin inhibition of adenylyl cyclase in lacrimal acinar cells.
    Cripps MM, Bennett DJ.
    Life Sci; 1992 Jul; 50(5):PL19-24. PubMed ID: 1732703
    [Abstract] [Full Text] [Related]

  • 11. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion.
    Onali P, Eva C, Olianas MC, Schwartz JP, Costa E.
    Mol Pharmacol; 1983 Sep; 24(2):189-94. PubMed ID: 6310360
    [Abstract] [Full Text] [Related]

  • 12. Additive effect of VIP or isoproterenol on forskolin-stimulated cyclic AMP accumulation in rat prostatic epithelial cells.
    Carmena MJ, Sancho JI, Prieto JC.
    Biochem Int; 1986 Sep; 13(3):479-85. PubMed ID: 3024642
    [Abstract] [Full Text] [Related]

  • 13. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS, Alfonzo M, Kowal J.
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [Abstract] [Full Text] [Related]

  • 14. The effect of vasoactive intestinal polypeptide (VIP) on forskolin stimulated adenylate cyclase in the caudate-putamen of the rat.
    Moser A, Drescher S.
    Exp Brain Res; 1990 Apr; 79(2):383-7. PubMed ID: 2323384
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y, Jakobs KH.
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [Abstract] [Full Text] [Related]

  • 16. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S, Sebben M, Garcia-Sainz JA, Bockaert J.
    Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin inhibits VIP- and forskolin-stimulated cyclic AMP accumulation in enterocytes from rat jejunum.
    Juarranz MG, Guijarro LG, Lopez-Ruiz MP, Prieto JC.
    Epithelial Cell Biol; 1992 Apr; 1(2):65-9. PubMed ID: 1364040
    [Abstract] [Full Text] [Related]

  • 18. Effects of forskolin on adenylate cyclase activity and amylase secretion in the rat exocrine pancreas.
    Dehaye JP, Gillard M, Poloczek P, Stievenart M, Winand J, Christophe J.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Apr; 10(3):269-80. PubMed ID: 2410466
    [Abstract] [Full Text] [Related]

  • 19. The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover.
    Ramkumar V, Stiles GL.
    Mol Pharmacol; 1988 Dec; 34(6):761-8. PubMed ID: 2849044
    [Abstract] [Full Text] [Related]

  • 20. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
    Turner JT, Bollinger DW, Toews ML.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):417-23. PubMed ID: 2846820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.